Neuro-Oncology Reviews

Volume 25 Number 4
28 February 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 4, 28 February

Pant A, Lim M.
CAR-T Therapy in GBM: Current Challenges and Avenues for Improvement.
Cancers (Basel). 2023 Feb 16;15(4):1249
. doi: 10.3390/cancers15041249. PMID: 36831591. Review. ˍ

Stella M, Baiardi G, Pasquariello S, Sacco F, Dellacasagrande I, Corsaro A, Mattioli F, Barbieri F.
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits.
Biomedicines. 2023 Feb 16;11(2):582
. doi: 10.3390/biomedicines11020582. PMID: 36831117. Review. ˍ

Chalif EJ, Foster C, Sack K, Patrick H, Mozaffari K, Rosner M.
Impact of Extent of Resection and Adjuvant Therapy in Diffuse Gliomas of the Spine.
Spine J. 2023 Feb 17:S1529-9430(23)00074-8
. doi: 10.1016/j.spinee.2023.02.010. PMID: 36804437. Observational study, Review˰ ˍ

Ibne Mokbul M, Siddik AB.
Relationship between glioblastoma multiforme (GBM) and Alzheimer's disease (AD): is there any reporting bias?
Med Oncol. 2023 Feb 21;40(3):101
. doi: 10.1007/s12032-023-01951-9. PMID: 36809382. Editorial˰ ˍ

Tamai S, Ichinose T, Nakada M.
Liquid biomarkers in glioma.
Brain Tumor Pathol. 2023 Feb 17
. doi: 10.1007/s10014-023-00452-x. PMID: 36800124. Review˰ ˍ

Angolkar M, Paramshetti S, Halagali P, Jain V, Patil AB, Somanna P.
Nanotechnological advancements in the brain tumor therapy: a novel approach.
Ther Deliv. 2023 Feb 21
. doi: 10.4155/tde-2022-0035. PMID: 36802944. Review˰ ˍ

De Roeck L, Gillebert RC, van Aert RCM, Vanmeenen A, Klein M, Taphoorn MJB, Gehring K, Lambrecht M, Sleurs C.
Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis.
Neuro Oncol. 2023 Feb 21:noad045
. doi: 10.1093/neuonc/noad045. PMID: 36809489. Meta-analysis. ˍ

Fudaba H, Wakimoto H.
Oncolytic virus therapy for malignant gliomas: entering the new era.
Expert Opin Biol Ther. 2023 Feb 21
. doi: 10.1080/14712598.2023.2184256. PMID: 36809883. Review˰ ˍ

Schaff LR, Mellinghoff IK.
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.
JAMA. 2023 Feb 21;329(7):574-587. doi: 10.1001/jama.2023.0023. PMID: 36809318. Review˰

Guzman G, Pellot K, Reed MR, Rodriguez A.
CAR T-cells to treat brain tumors.
Brain Res Bull. 2023 Feb 23:S0361-9230(23)00048-5
. doi: 10.1016/j.brainresbull.2023.02.014. PMID: 36841424. Review. ˍ

Barden MM, Omuro AM.
Top advances of the year: Neuro-oncology.
Cancer. 2023 Feb 24
. doi: 10.1002/cncr.34711. PMID: 36825454. Review˰ ˍ

Baqai MWS, Tariq R, Shah Z, Bajwa MH, Shamim MS.
Quality of life in survivors of pediatric medulloblastoma: a systematic review and meta-analysis.
Childs Nerv Syst. 2023 Feb 24
. doi: 10.1007/s00381-023-05886-4. PMID: 36826523. Review, Meta-analysis˰ ˍ

Schupper AJ, Hadjipanayis CG.
Novel approaches to targeting gliomas at the leading/cutting edge.
J Neurosurg. 2023 Feb 24:1-9
. doi: 10.3171/2023.1.JNS221798(?). PMID: 36840741. Review˰ ˍ

Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF, Goldbrunner R, Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane M, Razis E, Roth P, Rudà R, Tabatabai G, Wen PY, Short SC, Preusser M.
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
Neuro Oncol. 2023 Feb 27:noad038. doi: 10.1093/neuonc/noad038. PMID: 36843451. Review. ˍ